Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1351) 1351
Publication (103) 103
Book / eBook (48) 48
Book Review (18) 18
Magazine Article (4) 4
Book Chapter (3) 3
Conference Proceeding (1) 1
Dissertation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1333) 1333
male (898) 898
female (823) 823
middle aged (697) 697
anus neoplasms - drug therapy (639) 639
adult (579) 579
index medicus (541) 541
aged (529) 529
oncology (482) 482
anus neoplasms - pathology (428) 428
anus neoplasms - radiotherapy (428) 428
cancer (410) 410
anal cancer (335) 335
combined modality therapy (335) 335
radiotherapy (326) 326
antineoplastic combined chemotherapy protocols - therapeutic use (302) 302
chemotherapy (290) 290
carcinoma, squamous cell - drug therapy (284) 284
anus neoplasms - therapy (279) 279
treatment outcome (254) 254
fluorouracil - administration & dosage (248) 248
surgery (233) 233
aged, 80 and over (232) 232
carcinoma, squamous cell - radiotherapy (226) 226
retrospective studies (193) 193
anus neoplasms - surgery (189) 189
squamous-cell carcinoma (185) 185
care and treatment (169) 169
carcinoma, squamous cell - pathology (165) 165
hiv infections - complications (162) 162
follow-up studies (160) 160
anus neoplasms - virology (155) 155
neoplasm staging (155) 155
mitomycin (154) 154
mitomycin - administration & dosage (154) 154
risk factors (152) 152
hiv (148) 148
anus neoplasms - epidemiology (145) 145
carcinoma, squamous cell - therapy (143) 143
anus neoplasms - diagnosis (140) 140
anus neoplasms - mortality (139) 139
human papillomavirus (136) 136
anus (133) 133
prognosis (133) 133
chemoradiation (132) 132
radiotherapy dosage (122) 122
radiology, nuclear medicine & medical imaging (120) 120
carcinoma (118) 118
gastroenterology & hepatology (117) 117
epidermoid carcinoma (115) 115
cisplatin - administration & dosage (113) 113
medicine & public health (113) 113
5-fluorouracil (108) 108
survival rate (106) 106
antineoplastic agents - therapeutic use (104) 104
anus neoplasms - complications (103) 103
squamous cell carcinoma (102) 102
hiv infections - drug therapy (101) 101
therapy (100) 100
infectious diseases (99) 99
fluorouracil (97) 97
chemoradiotherapy (96) 96
radiation-therapy (95) 95
health aspects (92) 92
hematology, oncology and palliative medicine (91) 91
human-papillomavirus infection (87) 87
rectum (87) 87
papillomavirus infections - complications (86) 86
research (84) 84
cisplatin (81) 81
disease-free survival (81) 81
randomized-trial (81) 81
anus neoplasms - etiology (80) 80
active antiretroviral therapy (78) 78
prevalence (77) 77
antiretroviral therapy, highly active (76) 76
carcinoma, squamous cell - mortality (76) 76
incidence (76) 76
radiation (76) 76
diagnosis (75) 75
fluorouracil - therapeutic use (75) 75
papillomavirus infections (75) 75
anal canal - pathology (74) 74
human-immunodeficiency-virus (74) 74
management (73) 73
survival analysis (73) 73
prospective studies (72) 72
aids (69) 69
analysis (69) 69
drug therapy (67) 67
lymphatic metastasis (67) 67
time factors (67) 67
human-papillomavirus (65) 65
adolescent (64) 64
chemotherapy, adjuvant (64) 64
gastroenterology (63) 63
squamous intraepithelial lesions (63) 63
anus neoplasms (62) 62
anus neoplasms - prevention & control (61) 61
carcinoma, squamous cell - surgery (61) 61
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (40) 40
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Online Resources - Online (1) 1
St. Michael's Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1257) 1257
French (48) 48
German (34) 34
Japanese (29) 29
Spanish (11) 11
Russian (9) 9
Italian (8) 8
Czech (3) 3
Portuguese (3) 3
Danish (2) 2
Norwegian (2) 2
Chinese (1) 1
Dutch (1) 1
Finnish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/Cisplatin
by Leonard L. Gunderson and Kathryn A. Winter and Jaffer A. Ajani and John E. Pedersen and Jennifer Moughan and Al B. Benson III and Charles R. Thomas Jr and Robert J. Mayer and Michael G. Haddock and Tyvin A. Rich and Christopher G. Willett
Journal of Clinical Oncology, ISSN 0732-183X, 12/2012, Volume 30, Issue 35, pp. 4344 - 4351
Purpose On initial publication of GI Intergroup Radiation Therapy Oncology Group (RTOG) 98-11 [A Phase III Randomized Study of 5-Fluorouracil (5-FU),... 
THERAPY | CISPLATIN | ONCOLOGY | REPOPULATION | MITOMYCIN | LOCAL-CONTROL | RADIOTHERAPY | RADIATION | CANCER | CHEMOTHERAPY | Mitomycin - adverse effects | Recurrence | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Anus Neoplasms - surgery | Male | Survival Rate | Anus Neoplasms - pathology | Colostomy | Chemoradiotherapy | Cisplatin - administration & dosage | Young Adult | Disease-Free Survival | Neoplasm Metastasis | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Anus Neoplasms - drug therapy | Anus Neoplasms - radiotherapy | Survival Analysis | Cisplatin - adverse effects | Adult | Female | Mitomycin - administration & dosage | Gic4 | Gic6 | Gic5 | ORIGINAL REPORTS
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Induction Chemotherapy and Dose Intensification of the Radiation Boost in Locally Advanced Anal Canal Carcinoma: Final Analysis of the Randomized UNICANCER ACCORD 03 Trial
by Didier Peiffert and Laetitia Tournier-Rangeard and Jean-Pierre Gérard and Claire Lemanski and Eric François and Marc Giovannini and Frédérique Cvitkovic and Xavier Mirabel and Olivier Bouché and Elisabeth Luporsi and Thierry Conroy and Christine Montoto-Grillot and Françoise Mornex and Antoine Lusinchi and Jean-Michel Hannoun-Lévi and Jean-François Seitz and Antoine Adenis and Christophe Hennequin and Bernard Denis and Michel Ducreux
Journal of Clinical Oncology, ISSN 0732-183X, 06/2012, Volume 30, Issue 16, pp. 1941 - 1948
Purpose Concomitant radiochemotherapy (RCT) is the standard for locally advanced anal canal carcinoma (LAACC). Questions regarding the role of induction... 
5-FLUOROURACIL | CHEMORADIATION THERAPY | EPIDERMOID CARCINOMA | CISPLATIN | ONCOLOGY | EUROPEAN ORGANIZATION | PHASE-II | MITOMYCIN | RADIOTHERAPY | FLUOROURACIL | CANCER | Radiotherapy Dosage | Chemoradiotherapy - methods | Drug Administration Schedule | Humans | Middle Aged | Induction Chemotherapy | Male | Anal Canal | Cisplatin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Anus Neoplasms - drug therapy | Anus Neoplasms - radiotherapy | Anus Neoplasms - therapy | Adult | Female | Aged
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study
by Morris, Van K, MD and Salem, Mohamed E, MD and Nimeiri, Halla, MD and Iqbal, Syma, MD and Singh, Preet, MD and Ciombor, Kristen, MD and Polite, Blase, MD and Deming, Dustin, MD and Chan, Emily, MD and Wade, James L, MD and Xiao, Lianchun, MS and Bekaii-Saab, Tanios, Prof and Vence, Luis, PhD and Blando, Jorge, DVM and Mahvash, Armeen, MD and Foo, Wai Chin, MD and Ohaji, Chimela, MD and Pasia, Manolo, BSN and Bland, Gail, BS and Ohinata, Aki, PAC and Rogers, Jane, PharmD and Mehdizadeh, Amir, MA and Banks, Kimberly, MS and Lanman, Richard, MD and Wolff, Robert A, Prof and Streicher, Howard, MD and Allison, James, Prof and Sharma, Padmanee, Prof and Eng, Cathy, Prof
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 4, pp. 446 - 453
Summary Background Squamous cell carcinoma of the anal canal (SCCA) is a rare malignancy associated with infection by human papillomavirus (HPV). No consensus... 
Hematology, Oncology and Palliative Medicine | HUMAN-PAPILLOMAVIRUS TYPE-16 | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | CHEMORADIATION | RADIOTHERAPY | COMBINATION | PD-1 | CHEMOTHERAPY | MEMBER | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Salvage Therapy | Neoplasm Recurrence, Local - drug therapy | Antibodies, Monoclonal - therapeutic use | Male | Response Evaluation Criteria in Solid Tumors | Survival Rate | Antineoplastic Agents - therapeutic use | Anus Neoplasms - pathology | Lymphatic Metastasis | Case-Control Studies | Neoplasm Recurrence, Local - pathology | Carcinoma, Squamous Cell - drug therapy | Anus Neoplasms - drug therapy | Nivolumab | Carcinoma, Squamous Cell - secondary | Female | Aged | Neoplasm Staging | Drug Resistance, Neoplasm - drug effects | Proteins | Viral antibodies | Squamous cell carcinoma | Oncology, Experimental | Antibodies | Research | Metastasis | Papillomavirus infections | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text FOLFIRI regimen: An effective second-line chemotherapy after failure of etoposide-platinum combination in patients with neuroendocrine carcinomas grade 3
by Hentic, O and Hammel, P and Couvelard, A and Rebours, V and Zappa, M and Palazzo, M and Maire, F and Goujon, G and Gillet, A and Lévy, P and Ruszniewski, P
Endocrine-Related Cancer, ISSN 1351-0088, 12/2012, Volume 19, Issue 6, pp. 751 - 757
Patients with neuroendocrine carcinomas (NECs) grade 3 have a poor prognosis. Etoposide-platinum combination is the standard chemotherapy but the role of a... 
CONSENSUS GUIDELINES | PROGNOSTIC-FACTORS | CISPLATIN | ONCOLOGY | ENDOCRINOLOGY & METABOLISM | FLUOROURACIL FAILURE | PHASE-II | RANDOMIZED-TRIAL | IRINOTECAN | TUMORS | METASTATIC COLORECTAL-CANCER | DIFFERENTIATED ENDOCRINE CARCINOMAS | Humans | Middle Aged | Male | Platinum - administration & dosage | Pancreatic Neoplasms - drug therapy | Fluorouracil - therapeutic use | Neoplasm Grading | Pelvic Neoplasms - drug therapy | Adult | Female | Leucovorin - therapeutic use | Liver Neoplasms - pathology | Camptothecin - analogs & derivatives | Pelvic Neoplasms - pathology | Camptothecin - therapeutic use | Carcinoma, Neuroendocrine - drug therapy | Pancreatic Neoplasms - pathology | Liver Neoplasms - drug therapy | Etoposide - administration & dosage | Treatment Outcome | Anus Neoplasms - pathology | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Anus Neoplasms - drug therapy | Carcinoma, Neuroendocrine - pathology | Aged
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Fluorouracil, Mitomycin, and Radiotherapy vs Fluorouracil, Cisplatin, and Radiotherapy for Carcinoma of the Anal Canal: A Randomized Controlled Trial
by Ajani, Jaffer A and Winter, Kathryn A and Gunderson, Leonard L and Pedersen, John and Benson, Al B and Thomas, Charles R and Mayer, Robert J and Haddock, Michael G and Rich, Tyvin A and Willett, Christopher
JAMA, ISSN 0098-7484, 04/2008, Volume 299, Issue 16, pp. 1914 - 1921
CONTEXT Chemoradiation as definitive therapy is the preferred primary therapy for patients with anal canal carcinoma; however, the 5-year disease-free survival... 
5-FLUOROURACIL | MEDICINE, GENERAL & INTERNAL | CHEMORADIATION THERAPY | ONCOLOGY-GROUP | EPIDERMOID CARCINOMA | DOSE RADIATION-THERAPY | CLINICAL-TRIALS | SQUAMOUS-CELL CARCINOMA | PHASE-II | EUROPEAN-ORGANIZATION | CANCER | Humans | Middle Aged | Radiotherapy, High-Energy | Male | Combined Modality Therapy | Cisplatin - administration & dosage | Fluorouracil - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Anus Neoplasms - drug therapy | Anus Neoplasms - radiotherapy | Survival Analysis | Aged, 80 and over | Adult | Dose Fractionation | Female | Aged | Mitomycin - administration & dosage | Clinical trials | Oncology | Excretory system | Chemotherapy | Radiation therapy | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Neoadjuvant Cisplatin Chemotherapy Before Chemoradiation: A Flawed Paradigm?
by Rob Glynne-Jones and Peter Hoskin
Journal of Clinical Oncology, ISSN 0732-183X, 11/2007, Volume 25, Issue 33, pp. 5281 - 5286
Effective chemotherapy (CT) treatment of solid tumors emerged with the introduction of anthracyclines and platinum CT in the late 1970s, at first with... 
CELL LUNG-CANCER | PHASE-III TRIAL | ADVANCED NASOPHARYNGEAL CARCINOMA | GROWTH-FACTOR RECEPTOR | ADVANCED CERVICAL-CANCER | INDUCTION CHEMOTHERAPY | ONCOLOGY | THERAPY ONCOLOGY GROUP | RANDOMIZED-TRIAL | CONCURRENT CHEMORADIOTHERAPY | RADIATION-THERAPY | Carcinoma, Non-Small-Cell Lung - radiotherapy | Lung Neoplasms - drug therapy | Uterine Cervical Neoplasms - radiotherapy | Humans | Head and Neck Neoplasms - drug therapy | Lung Neoplasms - radiotherapy | Neoplasms - mortality | Uterine Cervical Neoplasms - drug therapy | Antineoplastic Agents - therapeutic use | Esophageal Neoplasms - radiotherapy | Urinary Bladder Neoplasms - drug therapy | Neoplasms - drug therapy | Head and Neck Neoplasms - radiotherapy | Urinary Bladder Neoplasms - radiotherapy | Cisplatin - therapeutic use | Anus Neoplasms - drug therapy | Anus Neoplasms - radiotherapy | Female | Neoadjuvant Therapy | Neoplasms - radiotherapy | Carcinoma, Non-Small-Cell Lung - drug therapy | Chemotherapy, Adjuvant | Esophageal Neoplasms - drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Prospective Study of Functional Bone Marrow-Sparing Intensity Modulated Radiation Therapy With Concurrent Chemotherapy for Pelvic Malignancies
by Liang, Yun, PhD and Bydder, Mark, PhD and Yashar, Catheryn M., MD and Rose, Brent S., MD and Cornell, Mariel, CMD and Hoh, Carl K., MD and Lawson, Joshua D., MD and Einck, John, MD and Saenz, Cheryl, MD and Fanta, Paul, MD and Mundt, Arno J., MD and Bydder, Graeme M., MD and Mell, Loren K., MD
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 85, Issue 2, pp. 406 - 414
Purpose To test the hypothesis that intensity modulated radiation therapy (IMRT) can reduce radiation dose to functional bone marrow (BM) in patients with... 
Radiology | Hematology, Oncology and Palliative Medicine | GYNECOLOGIC MALIGNANCIES | CISPLATIN | METABOLISM | ONCOLOGY | PHASE-III | RANDOMIZED-TRIAL | MITOMYCIN | RADIOTHERAPY | FLUOROURACIL | CANCER | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Prospective Studies | Radiotherapy Planning, Computer-Assisted - methods | Humans | Middle Aged | Uterine Cervical Neoplasms - blood | Magnetic Resonance Imaging - methods | Male | Tomography, X-Ray Computed | Uterine Cervical Neoplasms - pathology | Bone Marrow - radiation effects | Positron-Emission Tomography | Pelvis - diagnostic imaging | Radiotherapy, Intensity-Modulated - adverse effects | Cisplatin - administration & dosage | Feasibility Studies | Multimodal Imaging | Organ Sparing Treatments - methods | Fluorouracil - administration & dosage | Adult | Female | Bone Marrow - diagnostic imaging | Radiopharmaceuticals | Adipose Tissue - anatomy & histology | Chemoradiotherapy - methods | Uterine Cervical Neoplasms - radiotherapy | Radiotherapy, Intensity-Modulated - methods | Uterine Cervical Neoplasms - drug therapy | Adipose Tissue - diagnostic imaging | Anus Neoplasms - pathology | Tumor Burden | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Anus Neoplasms - blood | Anus Neoplasms - drug therapy | Anus Neoplasms - radiotherapy | Fluorodeoxyglucose F18 | Mitomycin - administration & dosage | Chemotherapy | Radiotherapy | Nuclear radiation | Cancer | Index Medicus | REVIEWS | PATIENTS | NEOPLASMS | FLUORODEOXYGLUCOSE | BONE MARROW | RADIATION DOSES | TOXICITY | SIMULATION | CHEMOTHERAPY | PLANNING | NMR IMAGING | POSITRON COMPUTED TOMOGRAPHY | HYPOTHESIS | MEN | VERTEBRAE | RADIOLOGY AND NUCLEAR MEDICINE | PELVIS | FLUORINE 18
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)
by Northover, J and Glynne-Jones, R and Sebag-Montefiore, D and James, R and Meadows, H and Wan, S and Jitlal, M and Ledermann, J
British Journal of Cancer, ISSN 0007-0920, 03/2010, Volume 102, Issue 7, pp. 1123 - 1128
BACKGROUND: The first UKCCCR Anal Cancer Trial (1996) demonstrated the benefit of chemoradiation over radiotherapy (RT) alone for treating epidermoid anal... 
Long-term follow-up | Anal cancer | Chemoradiation | ONCOLOGY | long-term follow-up | MITOMYCIN | SMOKING | RADIOTHERAPY | anal cancer | FLUOROURACIL | chemoradiation | CARCINOMA | Carcinoma - drug therapy | Follow-Up Studies | Mitomycin - therapeutic use | Humans | Carcinoma - mortality | Carcinoma - radiotherapy | Fluorouracil - therapeutic use | Fluorouracil - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Anus Neoplasms - drug therapy | Anus Neoplasms - radiotherapy | Anus Neoplasms - mortality | Survival Analysis | Radiotherapy, Adjuvant | Mitomycin - administration & dosage | Clinical Studies
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: Results of the UNICANCER ACCORD 16 phase II trial
by Deutsch, E and Lemanski, C and Pignon, J.P and Levy, A and Delarochefordiere, A and Martel-Lafay, I and Rio, E and Malka, D and Conroy, T and Miglianico, L and Becouarn, Y and Malekzadeh, K and Paris, E and Juzyna, B and Ezra, P and Azria, D
Annals of Oncology, ISSN 0923-7534, 11/2013, Volume 24, Issue 11, pp. 2834 - 2838
The ACCORD 16 phase II trial aimed to evaluate the objective response rate after combination of conventional chemoradiotherapy (CRT) and cetuximab in locally... 
Phase II | Cetuximab | Targeted therapy | Toxicity | Chemoradiotherapy | Anal cancer | toxicity | targeted therapy | CANAL CARCINOMA | EPIDERMOID CARCINOMA | cetuximab | chemoradiotherapy | RANDOMIZED-TRIAL | MITOMYCIN | anal cancer | CHEMOTHERAPY | RADIATION-THERAPY | phase II | 5-FLUOROURACIL | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | CHEMORADIATION | RADIOTHERAPY | Neoplasm Recurrence, Local - radiotherapy | Chemoradiotherapy - adverse effects | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Male | Anus Neoplasms - pathology | Radiotherapy - adverse effects | Cisplatin - administration & dosage | Drug-Related Side Effects and Adverse Reactions - pathology | Neoplasm Recurrence, Local - pathology | Disease-Free Survival | Antibodies, Monoclonal, Humanized - administration & dosage | Fluorouracil - administration & dosage | Anus Neoplasms - drug therapy | Anus Neoplasms - radiotherapy | Adult | Female | Aged | Drug-Related Side Effects and Adverse Reactions - classification | Index Medicus | Neoplasm Recurrence, Local | Radiotherapy | Anus Neoplasms | Cisplatin | Life Sciences | Antibodies, Monoclonal, Humanized | Drug-Related Side Effects and Adverse Reactions | Santé publique et épidémiologie | Fluorouracil
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Dose-Painted Intensity-Modulated Radiation Therapy for Anal Cancer: A Multi-Institutional Report of Acute Toxicity and Response to Therapy
by Kachnic, Lisa A., M.D and Tsai, Henry K., M.D and Coen, John J., M.D and Blaszkowsky, Lawrence S., M.D and Hartshorn, Kevan, M.D and Kwak, Eunice L., M.D., Ph.D and Willins, John D., Ph.D and Ryan, David P., M.D and Hong, Theodore S., M.D
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 1, pp. 153 - 158
Purpose Chemoradiation for anal cancer yields effective tumor control, but is associated with significant acute toxicity. We report our multi-institutional... 
Radiology | Hematology, Oncology and Palliative Medicine | IMRT | Anal cancer | Chemoradiation | Acute toxicity | CANAL CARCINOMA | RANDOMIZED-TRIAL | PHASE-II | MITOMYCIN | ONCOLOGY | CONCURRENT CHEMOTHERAPY | HIV-POSITIVE PATIENTS | SQUAMOUS-CELL CARCINOMA | TREATMENT TOLERANCE | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Chemoradiotherapy - adverse effects | Tumor Burden - radiation effects | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Urogenital System - radiation effects | Gastrointestinal Tract - radiation effects | Male | Carcinoma, Squamous Cell - diagnostic imaging | Carcinoma, Squamous Cell - radiotherapy | Radiotherapy, Intensity-Modulated - adverse effects | Cisplatin - administration & dosage | Fluorouracil - administration & dosage | Female | Retrospective Studies | Radiodermatitis - etiology | Lymphatic Irradiation - methods | Radiotherapy Dosage | Chemoradiotherapy - methods | Anus Neoplasms - diagnostic imaging | Actuarial Analysis - methods | Radiotherapy, Intensity-Modulated - methods | Treatment Outcome | Anus Neoplasms - pathology | Radiography | Disease-Free Survival | Carcinoma, Squamous Cell - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Anus Neoplasms - drug therapy | Hematologic Diseases - etiology | Anus Neoplasms - radiotherapy | Carcinoma, Squamous Cell - secondary | Drug Substitution | Mitomycin - administration & dosage | Care and treatment | Radiotherapy | Nuclear radiation | Health aspects | Cancer | Toxicity | Canals | Radiation | Radiation therapy | Survival | Metastases | Chemotherapy | Immunosuppression | Age | Tumors | squamous cell carcinoma | Index Medicus | PATIENTS | AIDS VIRUS | RECTUM | BIOPSY | METASTASES | FEMALES | RADIATION DOSES | TOXICITY | CHEMOTHERAPY | MEDICAL ESTABLISHMENTS | PLANNING | IMMUNOSUPPRESSION | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Combination chemotherapy for metastatic extramammary Paget disease
by Oashi, K and Tsutsumida, A and Namikawa, K and Tanaka, R and Omata, W and Yamamoto, Y and Yamazaki, N
British Journal of Dermatology, ISSN 0007-0963, 06/2014, Volume 170, Issue 6, pp. 1354 - 1357
Summary Background It is difficult to treat patients in the advanced stages of extramammary Paget disease (EMPD) because no effective treatment has yet been... 
ANTIBODIES | THERAPY | PHARMACOKINETICS | EFFICACY | SAFETY | ACTIVE RHEUMATOID-ARTHRITIS | RITUXIMAB | CHILDHOOD PEMPHIGUS-VULGARIS | TERM-FOLLOW-UP | OF-THE-LITERATURE | DERMATOLOGY | Lymph Node Excision | Paget Disease, Extramammary - surgery | Humans | Middle Aged | Bone Neoplasms - secondary | Anus Neoplasms - surgery | Male | Epirubicin - administration & dosage | Genital Neoplasms, Male - drug therapy | Fluorouracil - administration & dosage | Paget Disease, Extramammary - drug therapy | Aged, 80 and over | Vincristine - administration & dosage | Female | Retrospective Studies | Liver Neoplasms - secondary | Vulvar Neoplasms - surgery | Vulvar Neoplasms - drug therapy | Carboplatin - administration & dosage | Treatment Outcome | Combined Modality Therapy | Lymphatic Metastasis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Anus Neoplasms - drug therapy | Aged | Genital Neoplasms, Male - surgery | Mitomycin - administration & dosage | Chemotherapy | Anthracyclines | Mitomycin | Drug therapy, Combination | Metastasis | Cancer | Fluorouracil
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Clinical features and response to systemic therapy in a historical cohort of advanced or unresectable mucosal melanoma
by Shoushtari, Alexander N and Bluth, Mark J and Goldman, Debra A and Bitas, Christiana and Lefkowitz, Robert A and Postow, Michael A and Munhoz, Rodrigo R and Buchar, Gauri and Hester, Robert H and Romero, Jacqueline A and Fitzpatrick, Laura J and Weiser, Martin R and Panageas, Katherine S and Wolchok, Jedd D and Chapman, Paul B and Carvajal, Richard D
Melanoma Research, ISSN 0960-8931, 2017, Volume 27, Issue 1, pp. 57 - 64
There are very few data available regarding the pattern of first metastases in resected mucosal melanomas (MMs) as well as the response of advanced MM to... 
Prognosis | Metastasis | Cytotoxic therapy | Mucosal melanoma | MEDICINE, RESEARCH & EXPERIMENTAL | BIOCHEMOTHERAPY | DACARBAZINE | COMBINATION | prognosis | CHEMOTHERAPY | TEMOZOLOMIDE | DERMATOLOGY | TRIAL | cytotoxic therapy | METASTATIC MELANOMA | CISPLATIN | ONCOLOGY | metastasis | RANDOMIZED PHASE-II | mucosal melanoma | Health Status Indicators | Humans | Middle Aged | Male | Response Evaluation Criteria in Solid Tumors | Antineoplastic Agents - therapeutic use | Mucous Membrane | Molecular Targeted Therapy | Vaginal Neoplasms - drug therapy | Vulvar Neoplasms - pathology | Melanoma - genetics | Aged, 80 and over | Adult | Female | Proto-Oncogene Proteins c-kit - genetics | Retrospective Studies | Membrane Proteins - genetics | Vulvar Neoplasms - drug therapy | Head and Neck Neoplasms - drug therapy | Proportional Hazards Models | Vaginal Neoplasms - pathology | Survival Rate | Anus Neoplasms - pathology | Melanoma - secondary | Head and Neck Neoplasms - pathology | Antineoplastic Agents, Alkylating - therapeutic use | Gallbladder Neoplasms - drug therapy | Antineoplastic Agents, Immunological - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Anus Neoplasms - drug therapy | GTP Phosphohydrolases - genetics | L-Lactate Dehydrogenase - blood | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Aged | Gallbladder Neoplasms - pathology | Mutation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Preoperative Chemotherapy and Survival for Large Anorectal Gastrointestinal Stromal Tumors: A National Analysis of 333 Cases
by Hawkins, Alexander T and Hawkins, Alexander T and Wells, Katerina O and Wells, Katerina O and Krishnamurty, Devi Mukkai and Krishnamurty, Devi Mukkai and Hunt, Steven R and Hunt, Steven R and Mutch, Matthew G and Mutch, Matthew G and Glasgow, Sean C and Glasgow, Sean C and Wise, Paul E and Wise, Paul E and Silviera, Matthew L and Silviera, Matthew L
Annals of Surgical Oncology, ISSN 1068-9265, 5/2017, Volume 24, Issue 5, pp. 1195 - 1201
Anorectal gastrointestinal stromal tumors (GISTs) are exceedingly rare, and management remains controversial in regard to local resection (LR) and preoperative... 
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | SURGERY | PHASE-II TRIAL | THERAPY | PROGNOSTIC-FACTORS | ONCOLOGY | RESECTION | RECTUM | QUALITY-OF-LIFE | IMATINIB MESYLATE | CANCER DATA-BASE | ADJUVANT | FEATURES | Age Factors | United States | Humans | Middle Aged | Anus Neoplasms - surgery | Male | Antineoplastic Agents - therapeutic use | Young Adult | Imatinib Mesylate - therapeutic use | Gastrointestinal Stromal Tumors - pathology | Aged, 80 and over | Adult | Female | Neoadjuvant Therapy | Rectal Neoplasms - pathology | Chemotherapy, Adjuvant | Gastrointestinal Stromal Tumors - mortality | Rectal Neoplasms - drug therapy | Gastrointestinal Stromal Tumors - surgery | Rectal Neoplasms - surgery | Survival Rate | Anus Neoplasms - pathology | Tumor Burden | Rectal Neoplasms - mortality | Anus Neoplasms - drug therapy | Gastrointestinal Stromal Tumors - drug therapy | Anus Neoplasms - mortality | Aged | Neoadjuvant therapy | Chemotherapy | Analysis | Mortality | Health aspects | Drug approval | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Cetuximab plus chemoradiotherapy in immunocompetent patients with anal carcinoma: A phase II Eastern cooperative oncology group-American college of radiology imaging network cancer research group trial (E3205)
by Garg, Madhur K and Zhao, Fengmin and Sparano, Joseph A and Palefsky, Joel and Whittington, Richard and Mitchell, Edith P and Mulcahy, Mary F and Armstrong, Karin I and Nabbout, Nassim H and Kalnicki, Shalom and El-Rayes, Bassel F and Onitilo, Adedayo A and Moriarty, Daniel J and Fitzgerald, Thomas J and Benson, Al B
Journal of Clinical Oncology, ISSN 0732-183X, 03/2017, Volume 35, Issue 7, pp. 718 - 726
Purpose Squamous cell carcinoma of the anal canal (SCCAC) is characterized by high locoregional failure (LRF) rates after sphincter-preserving definitive... 
HEAD | CONVENTIONAL CHEMORADIOTHERAPY | CISPLATIN | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | CHEMORADIATION | MITOMYCIN | RADIOTHERAPY | COMBINATION | HUMAN-PAPILLOMAVIRUS INFECTION | HPV | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Male | Survival Rate | Anus Neoplasms - pathology | Carcinoma, Squamous Cell - radiotherapy | Carcinoma, Squamous Cell - immunology | Chemoradiotherapy | Cisplatin - administration & dosage | Disease-Free Survival | Anus Neoplasms - immunology | Carcinoma, Squamous Cell - drug therapy | Fluorouracil - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Anus Neoplasms - drug therapy | Anus Neoplasms - radiotherapy | Adult | Cetuximab - administration & dosage | Female | Aged | Immunocompetence | Neoplasm Staging | Index Medicus | ORIGINAL REPORTS | Combined Modality
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights